Literature DB >> 35672577

Construction of simple and sensitive pancreatitis related microRNA detection strategy via self-priming triggered cascade signal amplification.

Linhong Ning1, Heng Cheng2, Feng Yu2, Yuan Zhou3, Yang Xie4.   

Abstract

Pancreatic diseases, such as pancreatitis and pancreatic cancer, remain the most threatening gastrointestinal diseases with a high mortality due to atypical symptoms. MicroRNA plays crucial roles in regulating metastasis and cell proliferation of pancreatic cancer, constituting important biomarkers for the early diagnosis of pancreatic cancers. Herein, we develop a sensitive and simple exosomal miRNA detection method with only a dual-hairpin-probe. In detail, the dual-hairpin-probe is constructed through combination of two functional sections for both target miRNA identification and signal amplification. With only one probe, the method possesses the capability to avoid interferences from concentration changes of other probes, and exhibits a higher stability which is demonstrated through the obtained low coefficients of variation (CV) of 6.73%. With let-7a as detection target, the LOD of the established method is determined to be 243 aM, while maintaining a high discriminating capability towards let-7a homogenous miRNAs.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Catalytic hairpin assembly; Endonuclease; Exosomes; Klenow fragment polymerase; MicroRNA (miRNA)

Mesh:

Substances:

Year:  2022        PMID: 35672577     DOI: 10.1007/s00216-022-04147-8

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.478


  27 in total

1.  Quantitation of microRNAs by real-time RT-qPCR.

Authors:  Caifu Chen; Ruoying Tan; Linda Wong; Richard Fekete; Jason Halsey
Journal:  Methods Mol Biol       Date:  2011

2.  Acute pancreatitis due to tacrolimus in kidney transplant and review of the literature.

Authors:  Xiao-Hua Liu; Hao Chen; Ruo-Yun Tan; Can Luo
Journal:  J Clin Pharm Ther       Date:  2020-09-19       Impact factor: 2.512

3.  Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment.

Authors:  Wenxi Zhou; Yu Zhou; Xinli Chen; Tingting Ning; Hongyi Chen; Qin Guo; Yiwen Zhang; Peixin Liu; Yujie Zhang; Chao Li; Yongchao Chu; Tao Sun; Chen Jiang
Journal:  Biomaterials       Date:  2020-11-23       Impact factor: 12.479

Review 4.  Dilemma and Challenge of Immunotherapy for Pancreatic Cancer.

Authors:  Jia Wu; Jianting Cai
Journal:  Dig Dis Sci       Date:  2020-03-05       Impact factor: 3.199

Review 5.  Immunotherapy and Prevention of Pancreatic Cancer.

Authors:  Alexander H Morrison; Katelyn T Byrne; Robert H Vonderheide
Journal:  Trends Cancer       Date:  2018-04-30

6.  Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.

Authors:  Sushrut Kamerkar; Valerie S LeBleu; Hikaru Sugimoto; Sujuan Yang; Carolina F Ruivo; Sonia A Melo; J Jack Lee; Raghu Kalluri
Journal:  Nature       Date:  2017-06-07       Impact factor: 49.962

7.  Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells.

Authors:  K E Richards; A E Zeleniak; M L Fishel; J Wu; L E Littlepage; R Hill
Journal:  Oncogene       Date:  2016-09-26       Impact factor: 9.867

Review 8.  Challenges in diagnosis of pancreatic cancer.

Authors:  Lulu Zhang; Santosh Sanagapalli; Alina Stoita
Journal:  World J Gastroenterol       Date:  2018-05-21       Impact factor: 5.742

Review 9.  The involvement of exosomes in the diagnosis and treatment of pancreatic cancer.

Authors:  Abakundana Nsenga Ariston Gabriel; Fang Wang; Qinlian Jiao; Umwali Yvette; Xuemei Yang; Samed Ahmed Al-Ameri; Lutao Du; Yun-Shan Wang; Chuanxin Wang
Journal:  Mol Cancer       Date:  2020-08-27       Impact factor: 27.401

Review 10.  Severe acute pancreatitis: surgical indications and treatment.

Authors:  Max Heckler; Thilo Hackert; Kai Hu; Cristopher M Halloran; Markus W Büchler; John P Neoptolemos
Journal:  Langenbecks Arch Surg       Date:  2020-09-10       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.